"This prick is asking for someone here to bring him to task Somebody give me some dirt on this vacuous mass so we can at last unmask him I'll pull the trigger on it, someone load the gun and cock it While we were all watching, he got Washington in his pocket."
How is it a smart business decision when you jack the price up so high people can't afford it?
The majority of patients are on a copay system for RX meds, and as the CEO says in his Reddit post, they use co-pay cards to keep the OOP cost for the majority of consumers low. Their insurance is on the hook for the extra thousands, so they may not see the difference until their premiums shoot up. If they have coinsurance or an HDHP they will see the cost, but for the majority of patients they won't see it. I would have had no idea my drug increased 10x had I not seen the EOB amount when I was searching for another EOB on my insurer's website as my copay remained the same low copay with the copay card.
How is it a smart business decision when you jack the price up so high people can't afford it?
Not defending his move at all, because it's messed up. However it makes business sense because it will primarily affect HIV patients, who are almost universally insured. I remember when Norvir went from a dog drug with intolerable side effects to a backbone of HIV therapy. Abbott adjusted the price "accordingly", and providers were PISSED. However, most patients were none the wiser because the cost to them was still minimal. It's a shame that protections for the most vulnerable patient populations can be exploited so terribly, but this is a pretty sound business move on Turing's part. At least for the short term and until the broader pharma backlash begins.
"This prick is asking for someone here to bring him to task Somebody give me some dirt on this vacuous mass so we can at last unmask him I'll pull the trigger on it, someone load the gun and cock it While we were all watching, he got Washington in his pocket."